tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP

GT Biopharma (GTBP) Ownership - Who Owns GT Biopharma?

175 Followers

GT Biopharma (GTBP) Ownership Overview

The ownership structure of GT Biopharma (GTBP) stock is a mix of institutional, retail and individual investors. Approximately 6.41% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 93.59% is owned by Public Companies and Individual Investors.
0.00% Insiders
3.24% Mutual Funds
3.17% Other Institutional Investors
93.59% Public Companies and
Individual Investors

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 11, 2023
Breen Michael Martin
Executive Chairman/interim Ceo,director
Bought$25000
Apr 10, 2023
Ohri Manu
Cfo & Secretary
Bought$25000

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,080,675.00Institution2.61%250,716.60
1,080,675.00Institution2.61%250,716.60
205,010.00Institution0.49%47,562.32
32,905.00Institution0.08%7,633.96
16,775.00Institution0.04%3,891.80
6,559.00Institution0.02%1,521.69

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,080,675.00Institution2.61%250,716.60
205,010.00Institution0.49%47,562.32
32,905.00Institution0.08%7,633.96
16,775.00Institution0.04%3,891.80
6,559.00Institution0.02%1,521.69

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
804,500.00Institution1.94%201,447.00
276,175.00Institution0.67%69,154.00

FAQ

Who Owns GT Biopharma (GTBP)?
According to the latest TipRanks data, approximately 3.17% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 93.59% is held by retail investors.
    What percentage of GT Biopharma (GTBP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.17% of GT Biopharma (GTBP) stock is held by institutional investors.
      What percentage of GT Biopharma (GTBP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 93.59% of GT Biopharma (GTBP) stock is held by retail investors.
        Who owns the most shares of GT Biopharma (GTBP)?
        Vanguard owns the most shares of GT Biopharma (GTBP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis